LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company's Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company's Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular and cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy and other non-related facilities, nursing facilities, family health center, rural health clinic, and physician practice, as well as offers physical therapy services. The company's Healthcare Innovations (HCI) Services segment provides strategic health management services to accountable care organizations. As of December 31, 2020, it operated 537 home health services locations, 120 hospice locations, 124 community-based service locations, 11 long-term acute care hospitals with 12 locations, and 12 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
IPO Year: 2005
Exchange: NASDAQ
Website: lhcgroup.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/4/2022 | $172.00 → $170.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 3/10/2022 | $175.00 → $185.00 | Buy | Truist Securities |
| 2/28/2022 | $184.00 → $181.00 | Outperform | Credit Suisse |
| 2/24/2022 | $190.00 → $170.00 | Buy | Benchmark |
| 11/10/2021 | $149.00 → $151.00 | Market Perform | SVB Leerink |
| 11/5/2021 | $207.00 → $171.00 | Equal-Weight | Barclays |
| 11/5/2021 | $192.00 → $180.00 | Outperform | RBC Capital |
| 11/5/2021 | $191.00 → $184.00 | Outperform | Credit Suisse |
| 10/26/2021 | $209.00 → $150.00 | Outperform → Market Perform | Cowen & Co. |
| 10/19/2021 | $245.00 → $190.00 | Buy | Deutsche Bank |
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G/A - LHC Group, Inc (0001303313) (Subject)
SC 13G - LHC Group, Inc (0001303313) (Subject)
Agape Care Group, a leading hospice and palliative care provider, announced today that it is has appointed Carry vandenMaagdenberg as its Chief Technology and Innovation Officer and welcomes Matt Winer to the company as its Chief Operations Officer. Both leaders are health care industry veterans who will lead Agape Care Group forward as it continues to serve a growing number of patients across the Southeast region. Winer joins Agape Care Group from LHC Group (NASDAQ:LHCG) where he led the company's Home Health Division in the Northeast. He has health care experience in South Carolina, having served in operational leadership roles for MUSC Health based in Charleston. He has also led teams i
LAFAYETTE, La., Feb. 17, 2021 /PRNewswire/ -- LHC Group, Inc. (NASDAQ: LHCG) announced a number of corporate governance and board changes that will go into effect with the company's annual shareholder meeting on June 10, 2021. These changes include a mandatory retirement age of 75 for board members as well as the appointment of new chairs of the audit, compensation, corporate development and nominating and corporate governance committees. In addition, LHC Group announced that W.J. "Billy" Tauzin, will retire from the board, effective June 10, 2021. Following a long and distinguished career representing Louisiana's Third Congressional District in the U.S. House of Representatives, Congressm
RBC Capital Mkts downgraded LHC Group from Outperform to Sector Perform and set a new price target of $170.00 from $172.00 previously
Truist Securities reiterated coverage of LHC Group with a rating of Buy and set a new price target of $185.00 from $175.00 previously
Credit Suisse reiterated coverage of LHC Group with a rating of Outperform and set a new price target of $181.00 from $184.00 previously
Benchmark reiterated coverage of LHC Group with a rating of Buy and set a new price target of $170.00 from $190.00 previously
SVB Leerink reiterated coverage of LHC Group with a rating of Market Perform and set a new price target of $151.00 from $149.00 previously
Barclays reiterated coverage of LHC Group with a rating of Equal-Weight and set a new price target of $171.00 from $207.00 previously
RBC Capital reiterated coverage of LHC Group with a rating of Outperform and set a new price target of $180.00 from $192.00 previously
Credit Suisse reiterated coverage of LHC Group with a rating of Outperform and set a new price target of $184.00 from $191.00 previously
Cowen & Co. downgraded LHC Group from Outperform to Market Perform and set a new price target of $150.00 from $209.00 previously
Deutsche Bank reiterated coverage of LHC Group with a rating of Buy and set a new price target of $190.00 from $245.00 previously
S-8 POS - LHC Group, Inc (0001303313) (Filer)
8-K - LHC Group, Inc (0001303313) (Filer)
10-K - LHC Group, Inc (0001303313) (Filer)
8-K - LHC Group, Inc (0001303313) (Filer)
8-K - LHC Group, Inc (0001303313) (Filer)
10-Q - LHC Group, Inc (0001303313) (Filer)
8-K - LHC Group, Inc (0001303313) (Filer)
10-Q - LHC Group, Inc (0001303313) (Filer)
8-K - LHC Group, Inc (0001303313) (Filer)
8-K - LHC Group, Inc (0001303313) (Filer)
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- S&P SmallCap 600 constituent UFP Industries Inc. (NASD: UFPI) will replace LHC Group Inc. (NASD: LHCG) in the S&P MidCap 400, and Otter Tail Corp. (NASD: OTTR) will replace UFP Industries in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, February 23. S&P 500 constituent UnitedHealth Group Inc. (NYSE:UNH) is acquiring LHC Group in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effectiv
LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea
LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t
LAFAYETTE, La., Sept. 13, 2022 /PRNewswire/ -- LHC Group (NASDAQ:LHCG) and University of Maryland Medical System (UMMS) today announced the signing of a definitive agreement to form a new joint venture partnership to provide enhanced in-home healthcare services throughout a large portion of the state of Maryland. The partnership's combined assets will include multiple locations serving 20 Maryland counties, the city of Baltimore, and the greater metropolitan area. It is anticipated that the agreement will be finalized in the fourth quarter of 2022, subject to customary closing
Transaction expands services across 36 counties LAFAYETTE, La., Aug. 16, 2022 /PRNewswire/ -- LHC Group (NASDAQ:LHCG) today announced an agreement to purchase Three Rivers Home Health, a provider headquartered in Eastman, Ga. The acquisition includes nine total locations – expanding LHC Group's service footprint in 36 counties in the Certificate of Need state of Georgia. The acquisition is expected to close in the fourth quarter of 2022, subject to customary closing conditions. LHC Group expects annualized revenue from this purchase of approximately $12 million and that it wi
LAFAYETTE, La., Aug. 3, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results Net service revenue increased 5.5% to $576.2 million.Net income attributable to LHC Group's common stockholders was $10.6 million, or $0.35 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $29.8 million, or $0.98 adjusted earnings per diluted share.Adjusted EBITDA was $53.0 million.A reconciliation of all non-GAAP financial results in this release appears o
LAFAYETTE, La., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the additions of Michael Freeman as Chief Business Development Officer and Jeremy Trahan as Chief Legal Officer and Executive Vice President of Acquisitions and Strategic Transactions. Prior to joining the team at Viemed, Freeman and Trahan were executives at LHC Group, Inc ("LHC")(NASDAQ:LHCG), where together they directed and were integrally involved in over 100 transactions valued at approximately $1.9 billion, collectively. "We are thrilled to expand our team
LAFAYETTE, La., July 13, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the second quarter ended June 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, August 3, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the second quarter results. About LHC Group, Inc. LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around the n
LAFAYETTE, La., May 4, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended March 31, 2022. First Quarter 2022 Financial Results Net service revenue increased 8.9% to $571.5 million.Adjusted net revenue was $575.5 millionNet income attributable to LHC Group's common stockholders was $19.5 million, or $0.64 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $33.4 million, or $1.09 adjusted earnings per diluted share.Adjusted EBITDA was $54.5 million.A reconciliation of all non-GAAP finan
Joint venture agreement will expand services in seven Georgia counties LAFAYETTE, La., May 3, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced today that it has finalized a joint venture (JV) partnership for in-home healthcare services with Archbold Medical Center in Thomasville, Ga. The initial agreement was first announced by the two organizations in March. The agreement includes two locations serving Thomas, Brooks, Grady, Colquitt, Mitchell, Decatur, and Seminole counties, expanding LHC Group's service area to five additional counties. LHC Group's providers wil
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
4 - LHC Group, Inc (0001303313) (Issuer)
LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 Financial Results Net service revenue increased 2.0% to $576.9 million.Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.Adjusted EBITDA was $60.3 million.A reconciliation of all non-GAAP financial results in this release appea
LAFAYETTE, La., Oct. 19, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the third quarter ended September 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, November 2, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the third quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around t
LAFAYETTE, La., Aug. 3, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results Net service revenue increased 5.5% to $576.2 million.Net income attributable to LHC Group's common stockholders was $10.6 million, or $0.35 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $29.8 million, or $0.98 adjusted earnings per diluted share.Adjusted EBITDA was $53.0 million.A reconciliation of all non-GAAP financial results in this release appears o
LAFAYETTE, La., July 13, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the second quarter ended June 30, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, August 3, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the second quarter results. About LHC Group, Inc. LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around the n
LAFAYETTE, La., May 4, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended March 31, 2022. First Quarter 2022 Financial Results Net service revenue increased 8.9% to $571.5 million.Adjusted net revenue was $575.5 millionNet income attributable to LHC Group's common stockholders was $19.5 million, or $0.64 per diluted share.Adjusted net income attributable to LHC Group's common stockholders was $33.4 million, or $1.09 adjusted earnings per diluted share.Adjusted EBITDA was $54.5 million.A reconciliation of all non-GAAP finan
LAFAYETTE, La., April 25, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the first quarter ended March 31, 2022. LHC Group plans to issue its earnings results after the market closes on Wednesday, May 4, 2022. In light of the Company's previously announced agreement to combine with Optum, LHC Group will not conduct a quarterly earnings call to discuss the first quarter results. About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around the natio
AM Best has commented that the Credit Ratings (ratings) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) and its insurance subsidiaries remain unchanged following the announcement that the group will acquire LHC Group Inc. (LHC) (Lafayette, LA) (NASDAQ:LHCG), a national provider of home-health care services. The outlooks of the ratings remain stable. LHC is to be combined with UnitedHealth Group's Optum Health operations. The combination of LHC and Optum Health will aim to strengthen its presence for in-home care, which when facilitated through Optum Health's value-based care and experience, could become a lower-cost alternative to nursing homes and a way
LAFAYETTE, La., Feb.23, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter and year ended December 31, 2021. Fourth Quarter 2021 Financial Results Net service revenue increased 9.6% to $583.4 million. Net income attributable to LHC Group's common stockholders was $15.7 million, or $0.50 per diluted share. Adjusted net income attributable to LHC Group's common stockholders was $39.4 million, or $1.26 adjusted earnings per diluted share. Adjusted EBITDA was $61.6 million.Full Year 2021 Financial Results Net service revenue increa
LAFAYETTE, La., Jan. 26, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) today announced details for the release of its results for the fourth quarter and year ended December 31, 2021. LHC Group plans to issue its earnings release after the market closes on Wednesday, February 23, 2022, and will host a conference call on Thursday, February 24, 2022, at 9:00 a.m. Eastern time to discuss its fourth quarter 2021 results. The toll-free number to call for this interactive teleconference is (877) 407-9208 (international callers: (201) 493-6784). A telephonic replay of the confere
LAFAYETTE, La., Nov. 3, 2021 /PRNewswire/ -- LHC Group, Inc. (NASDAQ:LHCG) announced its financial results for the quarter ended September 30, 2021. Third Quarter 2021 Financial Results Net service revenue increased 6.6% to $565.5 million. Net income attributable to LHC Group's common stockholders was $27.7 million, or $0.88 per diluted share. Adjusted net income attributable to LHC Group's common stockholders was $45.7 million, or $1.45 adjusted earnings per diluted share. Adjusted EBITDA, less non-controlling interest, was $68.8 million. A reconciliation of all non-GAAP fi